Catalyst Crew Technologies Corp. (OTC: CCTC), a digital health and artificial intelligence technology company, announced today that it has established an operating presence in Venezuela by forming a wholly owned subsidiary. The move is part of the company's strategy to expand its healthcare technology initiatives in Latin America, focusing on telehealth infrastructure and AI-enabled healthcare analytics platforms.
The new subsidiary is intended to facilitate local operations, infrastructure development, and the planned deployment of the company's digital health and AI platforms. These include modular systems such as CardioAI, PulmoAI, and NeuroAI, which are designed to support remote patient monitoring, telehealth services, and AI-enabled healthcare analytics. Management believes that establishing a local entity in Venezuela provides a foundation for potential pilot programs, service deployment, and collaboration with healthcare providers and organizations within the country.
Dr. Kevin Rodan Levy, Chief Executive Officer of Catalyst Crew Technologies Corp., stated: “Establishing a local operating presence is an important step in executing our regional strategy. We believe that combining artificial intelligence-driven healthcare technologies with localized healthcare infrastructure can support more accessible and efficient delivery of medical services.”
The company intends to prioritize market development in Latin America, where technology-enabled healthcare solutions may help expand access to medical services, improve diagnostic capabilities, and support more efficient healthcare delivery. By integrating its AI platforms into broader healthcare services infrastructure, Catalyst Crew Technologies aims to address the growing demand for modernized healthcare delivery systems in emerging markets.
For more information, visit https://catalystcrewai.com or review the company's filings with the U.S. Securities and Exchange Commission at www.sec.gov.
